Group 1: Industry Overview - The light industry and beauty sector is expected to stabilize and improve due to the dual drivers of domestic demand policies and steady export growth [3] - The "14th Five-Year Plan" marks a year of enhanced domestic demand policies, coupled with consumers' increasing pursuit of high-quality living, creating significant growth opportunities for the industry [3] - The penetration rate of cross-border e-commerce has ample room for improvement, and the recovery of international relations and demand from emerging markets will further drive market expansion [3] Group 2: Beauty Sector - The cosmetics market is projected to grow steadily, with the skincare segment being the largest, reaching a market size of 4,619 billion yuan in 2024, and expected to grow at a CAGR of 8.6% from 2024 to 2029 [19] - The high-end cosmetics market is rapidly expanding, with the market size for high-end skincare products increasing from 749 billion yuan in 2019 to 1,144 billion yuan in 2024, reflecting a CAGR of 8.84% [19] - Key companies in the beauty sector include: - **Mao Geping**: Revenue reached 25.88 billion yuan in H1 2025, with a growth rate of 31.28% [23] - **Lin Qingxuan**: Revenue grew to 10.52 billion yuan in H1 2025, marking a 98.28% increase [27] - **Marubi**: Revenue is expected to reach 29.70 billion yuan in 2024, recovering from previous declines [32] Group 3: Medical Aesthetics - The medical aesthetics sector is facing short-term pressure due to cautious consumer spending, but the long-term growth potential remains strong, with a projected CAGR of 10%-15% from 2024 to 2027 [36] - The market penetration rate for medical aesthetics in China is currently at 4-5%, indicating a growth potential of 2-5 times compared to countries like the US and South Korea [36] - Key companies in the medical aesthetics sector include: - **Jinbo Biological**: Achieved revenue of 12.96 billion yuan in Q1-Q3 2025, with a year-on-year growth of 31.10% [45] Group 4: Daily Chemicals - The daily chemical industry is benefiting from domestic demand policies, with local brands poised to capture market share [49] - Companies such as **Dengkang Oral Care** and **Runben** are highlighted for their strong market positions and growth potential [51][55] - **Shanghai Jahwa** has shown significant growth, with revenue reaching 49.61 billion yuan in Q1-Q3 2025, reflecting a 10.83% increase [59] Group 5: Home Furnishing - The home furnishing sector is under pressure due to weak real estate sales, with a 15% decline in residential investment in 2025 [65] - National subsidies for home appliances and furnishings have provided some support, but the long-term effects are limited [65] - Leading companies such as **Oppein Home** and **Kuka Home** are noted for their strong channel capabilities and multi-category layouts [65]

雅迪控股(01585)盈喜后高开逾3%，截至发稿，涨3.03%，报11.56港元，成交额529.89万港元。 消息面上，1月6日，雅迪控股发布公告，集团预期于截至2025年12月31日止年度录得的纯利不少于人民 币29亿元，而2024年同期录得的纯利则为人民币12.7亿元。预期纯利增加乃主要由于电动两轮车销售增 加及优化产品结构所致。 ...

消息面上，1月6日，雅迪控股发布公告，集团预期于截至2025年12月31日止年度录得的纯利不少于人民 币29亿元，而2024年同期录得的纯利则为人民币12.7亿元。预期纯利增加乃主要由于电动两轮车销售增 加及优化产品结构所致。 智通财经APP获悉，雅迪控股(01585)盈喜后高开逾3%，截至发稿，涨3.03%，报11.56港元，成交额 529.89万港元。 ...

Major Events - Brain动极光-B (06681) signed important business cooperation agreements with Peking University Sixth Hospital and Shandong Mental Health Center [1] - Cohere New Energy (00182) successfully completed a secondary listing on the Singapore Stock Exchange [1] - Bole康视云-B (02592) submitted a clinical trial application for the new drug CBT-009 to the Drug Evaluation Center [1] - Yingtong Holdings (06883) established a partnership with the Italian high-end fragrance brand CULTI to strengthen its high-end fragrance distribution network in China [1] - Weimeng Group (02013) initiated a business cooperation with Taobao Flash Purchase [1] - Dali普控股 (01921) officially became a qualified supplier for Saudi Aramco [1] - Yiming Anke-B (01541) regained global rights for IMM2510 and IMM27M [1] - Yuexiu Property (00123) subsidiary Shanghai Yuheng won a land parcel in Shanghai's Pudong New District [1] Operating Performance - Jinxin Reproductive (01951) reported a further narrowing of the overall decline in IVF egg retrieval cycles to -1.4% for 2025 [1] - Poly Real Estate Group (00119) achieved a cumulative contract sales amount of approximately 50.2 billion yuan for 2025, a year-on-year decrease of 7.38% [1] - Yadea Holdings (01585) issued a profit warning, expecting annual net profit to be no less than 2.9 billion yuan [1] - Jindi Commercial Real Estate (00535) reported a cumulative contract sales total of approximately 10.696 billion yuan for 2025, a year-on-year decrease of 47.33% [1] - Greentown Management Holdings (09979) estimated the construction fee for newly developed projects in 2025 to be 9.35 billion yuan, a year-on-year increase of approximately 0.4% [1] - Sunac China (01918) achieved a cumulative contract sales amount of approximately 36.84 billion yuan for 2025, a year-on-year decrease of 21.85% [1]

经济观察网雅迪控股在港交所公告称，预期于截至2025年12月31日止年度录得的纯利不少于人民币29亿 元，而2024年同期录得的纯利则为12.7亿元，预期纯利增加乃主要由于电动两轮车销售增加及优化产品 结构所致。 ...

雅迪控股(01585)发布公告，集团预期于截至2025年12月31日止年度录得的纯利不少于人民币29亿元， 而2024年同期录得的纯利则为人民币12.7亿元。预期纯利增加乃主要由于电动两轮车销售增加及优化产 品结构所致。 ...

Core Viewpoint - Yadea Holdings (01585.HK) expects a significant increase in net profit for the fiscal year ending December 31, 2025, projecting at least RMB 2.9 billion, compared to RMB 1.27 billion for the same period in 2024. The anticipated profit growth is primarily attributed to increased sales of electric two-wheelers and optimized product structure [1]. Group 1 - The projected net profit for 2025 is at least RMB 2.9 billion [1] - The net profit for 2024 was RMB 1.27 billion [1] - The increase in net profit is driven by higher sales of electric two-wheelers and product optimization [1]

智通財經APP訊，雅迪控股(01585)發佈公告，集團預期於截至2025年12月31日止年度錄得的純利不少於 人民幣29億元，而2024年同期錄得的純利則爲人民幣12.7億元。預期純利增加乃主要由於電動兩輪車銷 售增加及優化產品結構所致。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Yadea Group Holdings Ltd. 雅迪集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1585） 正面盈利預告 本公告乃由雅迪集團控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據 香港聯合交易所有限公司證券上市規則第13.09(2)(a)條以及香港法例第571章證券 及期貨條例第XIVA部項下之內幕消息條文而作出。 本公司董事會（「董事會」）謹此知會本公司股東及潛在投資者，根據董事會對本集團 截至2025年12月31日止年度之未經審核綜合管理賬目及董事會現時可得之其他資料 所作之初步審閱，本集團預期於截至2025年12月31日止年度（「本期間」）錄得的純利 不少於人民幣29億元，而2024年同期錄得的純利則為人民幣12.7億元。預期純利增 加乃主要由於電動兩輪車銷售增加及優化產品結構所致。 於本公告日期，本公司正在落實本集團於本期間之綜合年度業績。本公告所載 ...

致：香港交易及結算所有限公司 公司名稱: 雅迪集團控股有限公司（於開曼群島註冊成立的有限公司） 呈交日期: 2026年1月5日 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01585 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.00001 USD | | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | | | | 本月底結存 | | | 5,000,000,000 | USD | | 0.00001 USD | ...